During the past decade, Meenakshi Mission Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meenakshi Mission Hospital" #1 sponsor was "Piramal Enterprises Limited" with 3 trials, followed by "Daiichi Sankyo, Inc." with 2 trials sponsored, "Dr. Reddy's Laboratories Limited" with 2 trials sponsored, "Karyopharm Therapeutics Inc" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meenakshi Mission Hospital" #1 collaborator was "Orient Europharma Co., Ltd." with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator, "Reliance Clinical Research Services (Navi Mumbai, India)" with 1 trials as a collaborator and "Teva Branded Pharmaceutical Products R&D, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Meenakshi Mission Hospital" are "Advanced Refractory Solid Tumors" (2 trials), "Adenocarcinoma of the Esophagus" (1 trials), "Advanced Breast Cancer" (1 trials), "Advanced Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Meenakshi Mission Hospital" in a lesser frequency.

Most popular intervention types in "Meenakshi Mission Hospital" are "Drug" (16 trials), "Radiation" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "Selinexor" (2 trials), "5-FU" (1 trials), "Bevacizumab as Avastin" (1 trials) and "Bevacizumab as MYL-1402O" (1 trials). Other intervention names were less common.

The vast majority of trials in "Meenakshi Mission Hospital" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Meenakshi Mission Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Meenakshi Mission Hospital, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Meenakshi Mission Hospital, 5 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".